2016年：

　　Li, D., von Schaewen, M., Wang, X., Tao, W., Zhang, Y., Li, L., Heller, B., Hrebikova, G., Deng, Q., Ploss, A., *Zhong, J., and Huang, Z. (2016) Altered glycosylation patterns increase immunogenicity of a subunit HCV vaccine inducing neutralizing antibodies which confer protection in mice. J Virol. 2016 Sep 14. pii: JVI.01462-16. (*co-corresponding author) 

　　Xu, Y., and Zhong, J. (2016)Innate immunity against hepatitis C virus. Current Opinion in Immunology.42:98-104. 

　　Fan, W., Xie, S., Zhao, X., Li, N., Chang, C., Li, L., Yu, G., Chi, X., Pan, Y., Niu, J., *Zhong, J., Sun, B. (2016) IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18.J Gen Virol.97(9):2210-20.(*co-corresponding author) 

　　2015年：

　　Li, D., Huang, Z. and Zhong, J. (2015)Hepatitis C virus vaccine development: old challenges and new opportunities. National Science Review, 2 (3): 285. 

　　Xiang, Y., Tang, J., Tao, W., Cao, X., Song, B. and Zhong, J. (2015)Identification of cholesterol-25-hydroxylase as a novel host restriction factor as a part of primary innate immune responses against hepatitis C virus infection. J. Virology,89:6805–6816.  

　　Cao,X., Ding, Q., Lu J.,Tao, W., Huang, B., Zhao, Y., Niu, J., Liu, Y.J. and Zhong, J. (2015) MDA5 Plays a Critical Role in Interferon Response during Hepatitis C Virus Infection. J. Hepatology. 62:771–778(The first two authors contributed equally) 

　　2014年：

　　Chen,W., Xu, Y., Li, H., Tao, W.,Xiang, Y.,Huang, B., Niu, J., *Zhong, J. andMeng, G. (2014)HCV Genomic RNA Activates the NLRP3 Inflammasome in Human Myeloid Cells. PLoS One,9(1):e84953 (*co-corresponding author). 

　　Lu, J., Xiang, Y.,Tao, W., Li,Q., Wang, N., Gao, Y., Xiang, X., Xie, Q., and Zhong, J. (2014) A novel strategy to develop robust infectious hepatitis C virus cell culture system directly from a clinical isolate. J. Virology, 88, 1484-1491. 

　　2013年：

　　Qi, Y., Xiang, Y., Wang, J., Qi, Y., Li, J., Niu, J., and Zhong, J. (2013)Inhibition of Hepatitis C Virus Infection by Polyoxometalates. Antiviral Research,100(2), 392-398. 

　　Lu, J., Tao, W., Li, R., Xiang, Y., Zhang, N., Xiang, X., Xie, Q., and Zhong, J. (2013)Construction and characterization of infectious hepatitis C virus chimera containing structural proteins directly from genotype 1b clinical isolates.Virology,443(1), 80-88. 

　　Ding, Q., Cao,X., Lu J.,Huang, B., Liu, Y.J., Kato, N., Shu, H., and Zhong, J. (2013) Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. J. Hepatology. 59(1):52-58.(The first two authors contributed equally) 

　　Kang,X., Chen,X., He,Y., Guo,D., Guo,L., *Zhong, J., Shu, H. (2013) DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus. Virology,435(2), 385-394. (*co-corresponding author)